Factor VII activating protease (FSAP) exerts anti-inflammatory and anti-fibrotic effects in liver fibrosis in mice and men

Journal of Hepatology

Volumn 58, Issue 1, 2013, Pages 104-111

  Borkham Kamphorst, Erawan ^a   Zimmermann, Henning W ^a   Gassler, Nikolaus ^a   Bissels, Ute ^b   Bosio, Andreas ^b   Tacke, Frank ^a   Weiskirchen, Ralf ^a   Kanse, Sandip M ^c,d  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b MILTENYI BIOTEC GMBH   (Germany)

^c UNIVERSITY OF OSLO   (Norway)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

HABP2; Liver fibrosis; Marburg I SNP

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; ANTIFIBROTIC AGENT; ANTIINFLAMMATORY AGENT; ASPARTATE AMINOTRANSFERASE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; COLLAGEN TYPE 1; CUTANEOUS T CELL ATTRACTING CHEMOKINE; CXCL16 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FACTOR VII ACTIVATING PROTEASE; FIBRONECTIN; INTERSTITIAL COLLAGENASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; SERINE PROTEINASE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STELLATE CELL; WILD TYPE;

ADOLESCENT; ADULT; AGED; ANIMALS; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; FEMALE; HEPATITIS; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; SERINE ENDOPEPTIDASES; TRANSCRIPTOME; YOUNG ADULT;

EID: 84871249419     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.09.007     Document Type: Article

References (29)

1. V. Hernandez-Gea, and S.L. Friedman Pathogenesis of liver fibrosis Annu Rev Pathol 6 2011 425 456
2. E. Mormone, J. George, and N. Nieto Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches Chem Biol Interact 193 2011 225 231
3. Q.M. Anstee, A. Dhar, and M.R. Thursz The role of hypercoagulability in liver fibrogenesis Clin Res Hepatol Gastroenterol 35 2011 526 533
4. K. Borensztajn, J.H. von der Thusen, M.P. Peppelenbosch, and C.A. Spek The coagulation factor Xa/protease activated receptor-2 axis in the progression of liver fibrosis: a multifaceted paradigm J Cell Mol Med 14 2010 143 153
5. L.I. Kang, and W.M. Mars Fibrinolytic factors in liver fibrosis Curr Pharm Biotechnol 12 2011 1441 1446
6. J. Romisch, and V.I.I. Factor Activating protease (FSAP): a novel protease in hemostasis Biol Chem 383 2002 1119 1124
7. J. Willeit, S. Kiechl, T. Weimer, A. Mair, P. Santer, and C.J. Wiedermann Marburg I polymorphism of factor VII-activating protease: a prominent risk predictor of carotid stenosis Circulation 107 2003 667 670
8. S. Trompet, D. Pons, S.M. Kanse, A.J.M. de Craen, M.A. Ikram, and J.J.W. Verschuren Factor VII activating protease (FSAP) polymorphism (G534E) is associated with increased risk for stroke and mortality Stroke Res Treat 2011 2011 424759
9. H.E. Wasmuth, C.G. Tag, E. Van de Leur, C. Hellerbrand, T. Mueller, and T. Berg The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BB Hepatology 49 2009 775 780
10. D. Sedding, J.M. Daniel, L. Muhl, K. Hersemeyer, H. Brunsch, and B. Kemkes-Matthes The G534E polymorphism of the gene encoding the factor VII-activating protease is associated with cardiovascular risk due to increased neointima formation J Exp Med 203 2006 2801 2807
11. F. Stephan, J.A. Hazelzet, I. Bulder, M.A. Boermeester, J.O. van Till, and T. van der Poll Activation of factor VII-activating protease in human inflammation: a sensor for cell death Crit Care 15 2011 R110
12. S. Yamamichi, Y. Fujiwara, T. Kikuchi, M. Nishitani, Y. Matsushita, and K. Hasumi Extracellular histone induces plasma hyaluronan-binding protein (factor VII activating protease) activation in vivo Biochem Biophys Res Commun 409 2011 483 488
13. N.H. Choi-Miura, K. Otsuyama, Y. Sano, K. Saito, K. Takahashi, and M. Tomita Hepatic injury-specific conversion of mouse plasma hyaluronan binding protein to the active hetero-dimer form Biol Pharm Bull 24 2001 892 896
14. M. Roderfeld, R. Weiskirchen, S. Atanasova, A.M. Gressner, K.T. Preissner, and E. Roeb Altered factor VII activating protease expression in murine hepatic fibrosis and its influence on hepatic stellate cells Liver Int 29 2009 686 691
15. M. Etscheid, N. Beer, J.A. Kress, R. Seitz, and J. Dodt Inhibition of bFGF/EGF-dependent endothelial cell proliferation by the hyaluronan-binding protease from human plasma Eur J Cell Biol 82 2004 597 604
16. S.M. Kanse, P.J. Declerck, W. Ruf, G. Broze, and M. Etscheid Factor VII-activating protease promotes the proteolysis and inhibition of tissue factor pathway inhibitor Arterioscler Thromb Vasc Biol 32 2012 427 433
17. M. Etscheid, N. Beer, E. Fink, R. Seitz, and D. Johannes The hyaluronan-binding serine protease from human plasma cleaves HMW and LMW kininogen and releases bradykinin Biol Chem 383 2002 1633 1643
18. N. Mambetsariev, T. Mirzapoiazova, B. Mambetsariev, S. Sammani, F.E. Lennon, and J.G. Garcia Hyaluronic Acid binding protein 2 is a novel regulator of vascular integrity Arterioscler Thromb Vasc Biol 30 2010 483 490
19. H.W. Zimmermann, S. Seidler, N. Gassler, J. Nattermann, T. Luedde, and C. Trautwein Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis PLoS One 6 2010 e21381
20. E. Hanson, S.M. Kanse, A. Joshi, K. Jood, S. Nilsson, and C. Blomstrand Plasma FVII-activating protease antigen and activity levels are increased in ischemic stroke J Thromb Haemost 10 2012 848 856
21. B.P. Zambrowicz, A. Abuin, R. Ramirez-Solis, L.J. Richter, J. Piggott, and H. BeltrandelRio Wnk1 kinase deficiency lowers blood pressure in mice. a gene-trap screen to identify potential targets for therapeutic intervention Proc Natl Acad Sci U S A 100 2003 14109 14114
22. K.R. Karlmark, H.W. Zimmermann, C. Roderburg, N. Gassler, H.E. Wasmuth, and T. Luedde The fractalkine receptor CXCR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes Hepatology 52 2010 1769 1782
23. M. Roderfeld, R. Weiskirchen, S. Wagner, M.L. Berres, C. Henkel, and J. Grotzinger Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice FASEB J 20 2006 444 454
24. S.S. Glaser, E. Gaudio, T. Miller, D. Alvaro, and G. Alpini Cholangiocyte proliferation and liver fibrosis Expert Rev Mol Med 11 2009 e7
25. M.A. Aller, J.L. Arias, I. Prieto, M. Losada, and J. Arias Bile duct ligation: step-by-step to cholangiocyte inflammatory tumorigenesis Eur J Gastroenterol Hepatol 22 2012 651 661
26. J.H. Jang, A. Rickenbacher, B. Humar, A. Weber, D.A. Raptis, and K. Lehmann Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation Hepatology 56 2012 209 218
27. A.M. Gressner, and R. Weiskirchen Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets J Cell Mol Med 10 2006 76 99
28. S.M. Kanse, M. Parahuleva, L. Muhl, B. Kemkes-Matthes, D. Sedding, and K.T. Preissner Factor VII-activating protease (FSAP): vascular functions and role in atherosclerosis Thromb Haemost 99 2008 286 289
29. H.W. Zimmermann, and F. Tacke Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis Inflamm Allergy Drug Targets 10 2011 509 536